Literature DB >> 15557174

Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223).

Nianyu Li1, Creg J Workman, Stefani M Martin, Dario A A Vignali.   

Abstract

Lymphocyte activation gene-3 (LAG-3; CD223) is a CD4-related transmembrane protein that binds to MHC class II molecules. We have recently shown that LAG-3 is required for maximal regulatory T cell function, and that ectopic expression of LAG-3 is sufficient to confer regulatory activity. In this study we show that LAG-3 is cleaved within the D4 transmembrane domain connecting peptide into two fragments that remain membrane associated: a 54-kDa fragment that contains all the extracellular domains and oligomerizes with full-length LAG-3 (70 kDa) on the cell surface via the D1 domain, and a 16-kDa peptide that contains the transmembrane and cytoplasmic domains. This NH(2)-terminal fragment is subsequently released as soluble LAG-3 (sLAG-3), a process that is increased after T cell activation in vitro and in vivo, and is found in the sera of C57BL/6 and RAG-1(-/-) mice. Modulation of LAG-3 cleavage may contribute to the function of this key regulatory T cell protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557174     DOI: 10.4049/jimmunol.173.11.6806

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

Review 1.  The companions: regulatory T cells and gene therapy.

Authors:  Saman Eghtesad; Penelope A Morel; Paula R Clemens
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

2.  Guiding dose selection of monoclonal antibodies using a new parameter (AFTIR) for characterizing ligand binding systems.

Authors:  Sameed Ahmed; Miandra Ellis; Hongshan Li; Luca Pallucchini; Andrew M Stein
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-04-29       Impact factor: 2.745

Review 3.  Inhibitory receptor agonists: the future of autoimmune disease therapeutics?

Authors:  Stephanie Grebinoski; Dario Aa Vignali
Journal:  Curr Opin Immunol       Date:  2020-06-30       Impact factor: 7.486

4.  LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes.

Authors:  Qianxia Zhang; Maria Chikina; Andrea L Szymczak-Workman; William Horne; Jay K Kolls; Kate M Vignali; Daniel Normolle; Maria Bettini; Creg J Workman; Dario A A Vignali
Journal:  Sci Immunol       Date:  2017-03-31

5.  Metalloproteases regulate T-cell proliferation and effector function via LAG-3.

Authors:  Nianyu Li; Yao Wang; Karen Forbes; Kate M Vignali; Bret S Heale; Paul Saftig; Dieter Hartmann; Roy A Black; John J Rossi; Carl P Blobel; Peter J Dempsey; Creg J Workman; Dario A A Vignali
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

Review 6.  Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor.

Authors:  Elisa Ruffo; Richard C Wu; Tullia C Bruno; Creg J Workman; Dario A A Vignali
Journal:  Semin Immunol       Date:  2019-04       Impact factor: 11.130

7.  Differential subcellular localization of the regulatory T-cell protein LAG-3 and the coreceptor CD4.

Authors:  Seng-Ryong Woo; Nianyu Li; Tullia C Bruno; Karen Forbes; Scott Brown; Creg Workman; Charles G Drake; Dario A A Vignali
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

8.  A molecule in teleost fish, related with human MHC-encoded G6F, has a cytoplasmic tail with ITAM and marks the surface of thrombocytes and in some fishes also of erythrocytes.

Authors:  Ken Ohashi; Fumio Takizawa; Norihiro Tokumaru; Chihaya Nakayasu; Hideaki Toda; Uwe Fischer; Tadaaki Moritomo; Keiichiro Hashimoto; Teruyuki Nakanishi; Johannes Martinus Dijkstra
Journal:  Immunogenetics       Date:  2010-07-08       Impact factor: 2.846

9.  Conserved regions from Neisseria gonorrhoeae pilin are immunosilent and not immunosuppressive.

Authors:  Johanna K Hansen; Karen P Demick; John M Mansfield; Katrina T Forest
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

10.  Potential role of decoy B7-H4 in the pathogenesis of rheumatoid arthritis: a mouse model informed by clinical data.

Authors:  Takeshi Azuma; Gefeng Zhu; Haiying Xu; A Cecilia Rietz; Charles G Drake; Eric L Matteson; Lieping Chen
Journal:  PLoS Med       Date:  2009-10-20       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.